• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

52.4100 USD 0.5300 1.02%

As of 20:04:04 ET on 12/19/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 52.1100 High - Low: 52.7700 - 51.6001 Primary Exchange: NYSE Arca
Volume: 83,318 52-Week Range: 35.9300 - 52.7700 Beta vs DZOTR: 1.0004

ETF Chart for PBE

No chart data available.
  • PBE:US 52.4100
  • 1D
  • 1M
  • 1Y
51.8800
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD / MICHAEL JEANETTE
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-12-19) 52.2692
Assets (M) (on 2014-12-19) 470.4225
Shares out (M) 9.00
Market Cap (M) 471.69
% Premium 0.27
Average 52-Week % Premium 0.0039
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.53%

Performance for PBE

1-Month +5.96% 1-Year +46.90%
3-Month +13.54% 3-Year +40.34%
Year To Date +42.34% 5-Year +26.65%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 12/19/2014
Name Position Value % of Total
Biogen Idec Inc 74,063 26,712,302 5.678%
Gilead Sciences Inc 227,161 24,635,610 5.236%
BioMarin Pharmaceutical Inc 254,000 23,835,360 5.066%
Amgen Inc 137,855 23,458,785 4.986%
Regeneron Pharmaceuticals Inc 54,766 23,420,132 4.978%
Sigma-Aldrich Corp 166,829 22,773,827 4.841%
Illumina Inc 119,382 22,678,999 4.821%
Alexion Pharmaceuticals Inc 116,927 22,161,174 4.711%
Isis Pharmaceuticals Inc 240,014 15,622,511 3.321%
Insys Therapeutics Inc 320,948 14,551,782 3.093%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil